Author:
Park Jaeyeong,Shin Eunkyoung,Yeom Ji-Hyun,Choi Younkyung,Joo Minju,Lee Minho,Kim Je Hyeong,Bae Jeehyeon,Lee Kangseok
Publisher
Springer Science and Business Media LLC
Subject
Applied Microbiology and Biotechnology,General Medicine,Microbiology
Reference65 articles.
1. Almaaytah, A., Mohammed, G.K., Abualhaijaa, A., and Al-Balas, Q. 2017. Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria. Drug Des. Devel. Ther. 11, 3159–3170.
2. Bassetti, M., Ginocchio, F., and Mikulska, M. 2011 New treatment options against Gram-negative organisms. In Vincent, J.L. (ed.), Annual Update in Intensive Care and Emergency Medicine 2011, vol. 1. Springer, Berlin, Germany.
3. Bergogne-Bérézin, E. and Towner, K.J. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9, 148–165.
4. Blot, S., Vandewoude, K., and Colardyn, F. 2003. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med. 29, 471–475.
5. Carratalá, J.V., Serna, N., Villaverde, A., Vázquez, E., and Ferrer-Miralles, N. 2020. Nanostructured antimicrobial peptides: the last push towards clinics. Biotechnol. Adv. 44, 107603.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献